SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (23014)7/9/1998 11:53:00 PM
From: Phil Cressman  Respond to of 32384
 
Thanks Henry, feeling better about averaging down two weeks ago and today picking up 20,000 SRGN which will bounce with Ligand. Sure would be nice though if people knew that a compound which looks likely to work on human blood cells is in development. Maybe then we'd see LGND up around the $20 all we long time holders feel is justified.



To: Henry Niman who wrote (23014)7/10/1998 7:17:00 AM
From: Mudcat  Read Replies (1) | Respond to of 32384
 
<you will see that the current status of the SBH/LGND collaboration indicates that the lead compound has been selected.>

Henry: Do you or anyone know just what Lgnd gets as part of this collaboration? Will this be Lgnd's drug if developed or will they get some royalty %? This one compound appears to be for boosting the immune system after chemo, what about the other areas you have posted about? Are these all owned by Lgnd or shared with SBH?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News